Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

13.31
-0.3700-2.70%
Post-market: 13.310.00000.00%16:00 EDT
Volume:2.54M
Turnover:33.97M
Market Cap:1.64B
PE:-10.28
High:13.66
Open:13.64
Low:13.20
Close:13.68
Loading ...

BofA Securities Cuts Price Target on 10x Genomics to $12 From $16, Neutral Rating Maintained

MT Newswires Live
·
14 Apr

AI Biotech Stocks Shined. Recursion Soared 20% And Absci Surged 13%

Tiger Newspress
·
11 Apr

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
10 Apr

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

StockStory
·
10 Apr

BUZZ-Impact of NIH job cuts "better than feared" for life sciences firms, Leerink says

Reuters
·
27 Mar

We Think 10x Genomics (NASDAQ:TXG) Can Easily Afford To Drive Business Growth

Simply Wall St.
·
27 Mar

2 Reasons to Sell TXG and 1 Stock to Buy Instead

StockStory
·
11 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

10x Genomics Is Maintained at Buy by Citigroup

Dow Jones
·
05 Mar

10x Genomics price target lowered to $15 from $20 at Citi

TIPRANKS
·
04 Mar

10x Genomics secures injunction against Parse Biosciences’ planned ATAC products

TIPRANKS
·
04 Mar

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

PR Newswire
·
04 Mar

1 Stock Under $50 on Our Watchlist and 2 to Ignore

StockStory
·
03 Mar

AI Biotech Stocks Tumbled, with HIMS Plunging 17% and TEM Slumping 15%

Tiger Newspress
·
25 Feb

AI Biotech Stocks Shined, with Recursion and Tempus Jumping 5%

Tiger Newspress
·
24 Feb

10x Genomics unveils roadmap at AGBT general meeting

TIPRANKS
·
24 Feb

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

PR Newswire
·
24 Feb

Genetics Tools Face Fund Cuts -- Barron's

Dow Jones
·
15 Feb

10x Genomics (TXG) Receives a Buy from Morgan Stanley

TIPRANKS
·
14 Feb

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
14 Feb